This announcement is a separate document:
康辰药业关于股份性质变更暨2023年限制性股票激励计划授予的进展公告
Kangchen Pharmaceutical\'s announcement on changes in the nature of shares and progress in awarding the 2023 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.